The green synthesis
of nanoparticles using plant extract is a new
method that can be used in various biomedical applications. Therefore,
the green approach was an aspect of ongoing research for the synthesis
titanium dioxide nanoparticles (TiO2 NP) using the Solanum surattense aqueous plant extract, which acts as
a stabilizing and reducing agent. The synthesis of TiO2 NPs was confirmed by energy dispersive X-ray (EDX), scanning electron
microscopy (SEM), X-ray diffraction (XRD), Fourier transform infrared
spectroscopy (FT-IR), and UV–visible spectroscopy (UV–vis)
analyses. The excitation energy to synthesize TiO2 NPs
was identified through the UV–vis spectrophotometric analysis
at a wavelength of 244 nm. Further, the FT-IR spectroscopy visualized
different biomolecules like OH, CO, C–H, and C–O
that were present in an aqueous extract of the plant and were responsible
for the stabilization of TiO2 NPs. The crystallinity and
phase purity of TiO2 NPs were illustrated by the sharp
peaks of the XRD pattern. The spherical morphology with sizes ranging
from 10 to 80 nm was examined using SEM images. The elemental composition
of TiO2 NPs was revealed by the intensity and narrow widths
of titanium and oxygen using EDX analysis. This report also explains
the antiepileptic activity of TiO2 NPs in a maximal electroshock-induced
epileptic (MESE) and pentylenetetrazol (PTZ) model. The synthesized
TiO2 NPs showed maximum antiepileptic activity in the PTZ
model, significantly decreasing the convulsions (65.0 ± 5.50
s) at 180 mg/kg in contrast to standard drug phenytoin, whereas the
MESE model was characterized by the appearance of extensor, clonus,
and flexion. The results showed that synthesized TiO2 NPs
significantly reduced the time spent in each stage (15.3 ± 0.20,
16.8 ± 0.25, and 20.5 ± 0.14 s) at 180 mg/kg as compared
to control groups. Furthermore, the cytotoxicity of synthesized produced
TiO2 NPs demonstrated that concentrations ≤80 μg/mL
were biologically compatible.